| Exforge 10 mg/160 mg film-coated tablets EU/1/06/370/017-024 |
Valsartan, Amlodipine besilate |
Novartis Europharm Limited |
— |
| Exforge 5 mg/160 mg film-coated tablets EU/1/06/370/009-016 |
Amlodipine besilate, Valsartan |
Novartis Europharm Limited |
— |
| Exforge 5 mg/80 mg film-coated tablets EU/1/06/370/001-008 |
Amlodipine besilate, Valsartan |
Novartis Europharm Limited |
— |
| Exforge HCT 10 mg/160 mg/12.5 mg film-coated tablets EU/1/09/569/13-24 |
Hydrochlorothiazide, Valsartan, Amlodipine besilate |
Novartis Europharm Limited |
— |
| Exforge HCT 10 mg/160 mg/25 mg film-coated tablets EU/1/09/569/37-48 |
Hydrochlorothiazide, Valsartan, Amlodipine besilate |
Novartis Europharm Limited |
— |
| Exforge HCT 10 mg/320 mg/25 mg film-coated tablets EU/1/09/569/49-60 |
Valsartan, Hydrochlorothiazide, Amlodipine besilate |
Novartis Europharm Limited |
— |
| Exforge HCT 5 mg/160 mg/12.5 mg film-coated tablets EU/1/09/569/1-12 |
Amlodipine besilate, Hydrochlorothiazide, Valsartan |
Novartis Europharm Limited |
— |
| Exforge HCT 5 mg/160 mg/25 mg film-coated tablets EU/1/09/569/25-36 |
Amlodipine besilate, Hydrochlorothiazide, Valsartan |
Novartis Europharm Limited |
— |
| Exjade 180 mg film-coated tablets EU/1/06/356/014-016 |
Deferasirox |
Novartis Europharm Limited |
— |
| Exjade 180 mg granules in sachet EU/1/06/356/021 |
Deferasirox |
Novartis Europharm Limited |
— |
| Exjade 360 mg film-coated tablets EU/1/06/356/017-019 |
Deferasirox |
Novartis Europharm Limited |
— |
| Exjade 360 mg granules in sachet EU/1/06/356/022 |
Deferasirox |
Novartis Europharm Limited |
— |
| Exjade 90 mg film-coated tablets EU/1/06/356/011-013 |
Deferasirox |
Novartis Europharm Limited |
— |
| Exjade 90 mg granules in sachet EU/1/06/356/020 |
Deferasirox |
Novartis Europharm Limited |
— |
| Exjade Dispersible EU/1/06/356/001-009 |
Deferasirox |
Novartis Europharm Limited |
— |
| EXPAREL liposomal EU/1/20/1489/001-004 |
Bupivacaine |
Pacira Ireland Limited |
— |
| Eydenzelt 40 mg/mL solution for injection in a vial EU/1/24/1895/002 |
Afibercept |
Celltrion Healthcare Hungary Kft. |
— |
| Eydenzelt 40 mg/mL solution for injection in pre-filled syringe EU/1/24/1895/001 |
Afibercept |
Celltrion Healthcare Hungary Kft. |
— |
| Eylea 114.3 mg/ml solution for injection EU/1/12/797/003 |
Aflibercept |
Bayer AG |
— |
| Eylea 114.3 mg/ml solution for injection in pre-filled syringe EU/1/12/797/004 |
Aflibercept |
Bayer AG |
— |
| Eylea 40 mg/mL solution for injection EU/1/12/797/001-002 |
Aflibercept |
Bayer AG |
— |
| Eyluxvi 40mg/ml Solution for injection in vial EU/1/25/1972/001 |
Aflibercept |
Biolitec Pharma Limited |
— |
| Ezetimibe Rowa 10 mg tablets PA0074/074/001 |
Ezetimibe |
Rowa Pharmaceuticals Limited, |
Marketed |
| Ezmekly 1 mg dispersible tablets EU/1/25/1950/001-002 |
Mirdametinib |
Merck Europe B.V. |
— |
| Ezmekly 1 mg hard capsules EU/1/25/1950/003 |
Mirdametinib |
Merck Europe B.V. |
— |
| Ezmekly 2 mg hard capsules EU/1/25/1950/004-005 |
Mirdametinib |
Merck Europe B.V. |
— |
| FABHALTA 200 mg hard capsules EU/1/24/1802/001-003 |
Iptacopan |
Novartis Europharm Limited |
— |
| Fabrazyme 35 mg powder for concentrate for solution for infusion EU/1/01/188/001-003 |
Agalsidase Beta |
Sanofi B.V. |
— |
| Fabrazyme 5 mg powder for concentrate for solution for infusion EU/1/01/188/004-006 |
Protein c agalsidase beta (recombinant human-a-galactoside a) |
Sanofi B.V. |
— |
| Fampridine Accord 10 mg prolonged-release tablets EU/1/20/1477/001-002 |
Fampridine |
Accord Healthcare S.L.U. |
— |
| Fampridine Rowa 10 mg prolonged-release tablets PA0074/087/001 |
Fampridine |
Rowa Pharmaceuticals Limited |
Not marketed |
| Fampyra 10 mg prolonged-release tablets EU/1/11/699/001-002 |
Fampridine |
Merz Pharmaceuticals GmbH |
— |
| Fareston 60 mg Tablets EU/1/96/004/001 |
Toremifene citrate |
Orion Corporation |
— |
| Fareston 60 mg Tablets EU/1/96/004/002 |
Toremifene |
Orion Corporation |
— |
| Farydak 10 mg hard capsules EU/1/15/1023/001-003 |
Panobinostat |
pharmaand GmbH |
— |
| Farydak 15 mg hard capsules EU/1/15/1023/004-006 |
Panobinostat |
pharmaand GmbH |
— |
| Farydak 20 mg hard capsules EU/1/15/1023/007-009 |
Panobinostat |
pharmaand GmbH |
— |
| Fasenra 30 mg solution for injection EU/1/17/1252/001-002 |
Benralizumab |
AstraZeneca AB |
— |
| Faslodex 250 mg Solution for injection EU/1/03/269/001-002 |
Fulvestrant |
AstraZeneca AB |
— |
| Fastum 2.5% w/w Gel PA0512/001/001 |
Ketoprofen |
A. Menarini Industrie Farmaceutische Riunite S.r.l. |
Marketed |
| Fasturtec 1.5 mg/ml powder and solvent for concentrate for solution for infusion EU/1/00/170/001-002 |
Rasburicase |
Sanofi Winthrop Industrie |
— |
| Febuxostat Krka 120 mg film-coated tablets EU/1/18/1347/005-008 |
Febuxostat |
KRKA, d.d., Novo mesto |
— |
| Febuxostat Krka 80 mg film-coated tablets EU/1/18/1347/001-004 |
Febuxostat |
KRKA, d.d., Novo mesto |
— |
| Febuxostat Rowa 120 mg film-coated tablets PA0074/085/002 |
Febuxostat |
Rowa Pharmaceuticals Limited, |
— |
| Febuxostat Rowa 80 mg film-coated tablets PA0074/085/001 |
Febuxostat |
Rowa Pharmaceuticals Limited, |
— |
| Febuxostat Viatris 120 mg film-coated tablets EU/1/17/1194/009-016 |
Febuxostat |
Viatris Limited |
— |
| Febuxostat Viatris 80 mg film-coated tablets EU/1/17/1194/001-008 |
Febuxostat |
Viatris Limited |
— |
| Fendrix suspension for injection EU/1/04/0299/001-003 |
Hepatitis b vaccine |
GlaxoSmithKline Biologicals S.A. |
— |
| Fenopine 200 mg/5 ml Oral Suspension PA0281/088/005 |
Ibuprofen ph. eur. |
Pinewood Laboratories Limited |
Not marketed |
| Fentanyl 100 micrograms in 2 ml Solution for Injection PA0073/122/001 |
FENTANYL CITRATE |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |